Medical AI Patents: Who Leads, Where the Gaps Are 2026
- Filings nearly tripled from 2021 to 2024 (+200%), with 2025 posting the highest count so far at 95 published records — though the most recent years are still filling in.
- The top 5 assignees hold just 22.6% of all 221 records, and the top 10 combine for only 33.0% — a long tail of single- and few-filing entrants dominates this field.
- G06N and G16H cover the majority of records (65.6% and 58.4%), but control-systems class G05B appears in only 3.6% of filings, marking a thin edge of the landscape.
Filing growth compares 2021 (10 records) with 2024 (30) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 221 records in scope (CR5), not by the ranked leaders only.
What this landscape covers
This landscape tracks 221 published patent records filed between 2015 and 2026 that combine Medical AI claim language with clinical-analytics elements such as training datasets, model parameters, feature vectors, model inference, patient records, or clinical decision logic. The scope spans diagnostic support, image-based analysis and healthcare informatics systems rather than AI methods generically. Publication lags filing by roughly 18 months, so the 2025 and 2026 figures in this dataset are undercounts of the eventual totals.
Filing activity is concentrated in India and the United States as receiving offices, with a smaller volume routed through the WIPO PCT system and single-digit counts in China, Australia and Hong Kong. That distribution reflects where applicants are choosing to establish priority and file nationally, not where the underlying research originates.
Let an AI agent run this analysis on your own technology
Pick a task. Every answer cites the patents behind it.
Filing trends and technology composition
Two views of the same 221-record dataset: how filing volume has moved year over year, and which IPC subclasses the claims actually sit in.
Filing trend: a sharp climb through 2024, with early 2025-26 data still incomplete
Volume moved from zero in 2017 to a peak of 95 in 2025, with growth from 2021 (10 records) to 2024 (30 records) representing a +200% increase over that three-year span — the last span the dataset can treat as complete.
Technology composition: AI computing and healthcare informatics dominate
G06N (AI models) and G16H (healthcare informatics) each cover more than half of all 221 records, while A61B, G06T, G06F and G06V form a substantial second tier. Because records can carry multiple IPC classes, these shares add up to more than 100% and should be read as claim-coverage overlap, not as mutually exclusive segments.
Shares are the percentage of the 221 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Medical AI & Clinical Analytics Patent Landscape with Eureka
This page is one run against one query. Ask Eureka your own question about medical ai & clinical analytics patent landscape and every answer comes back with the patent numbers behind it.
Try EurekaRepresentative filing and most-cited records
AI clinical decision support system using connectivity model analysis
The present disclosure provides an AI-based clinical decision support system comprising an input module configured to receive clinical information comprising brain scan data, an analysis module configured to parse the clinical information using statistical measures from functional connectivity analysis with counterfactual explanations to identify brain connectivity patterns associated with brain disorders, and an output module configured to present a recommended diagnosis and explanation comprising attribution information identifying connectivity features contributing to the diagnosis.Filed by University of Sharjah, published 2026-07-02. Covers fMRI and EEG-based connectivity analysis with counterfactual explanation of the diagnosis output.

| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US20200268260A1 | Hearing and monitoring system | 109 |
| 2 | US20210256160A1 | Method and system for automated text anonymisation | 63 |
| 3 | US20250259041A1 | Ai agent decision platform with deontic reasoning | 62 |
| 4 | US20200117897A1 | Adaptive Artificial Intelligence Training Data Acquisition and Plant Monitoring System | 58 |
| 5 | US20250259082A1 | Ai agent decision platform with deontic reasoning and quantum-inspired token management | 49 |
| 6 | US20210052252A1 | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and ai recognition of 2d … | 37 |
| 7 | US20210259664A1 | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device | 33 |
| 8 | US20210201190A1 | Machine learning model development and optimization process that ensures performance validation and data suff… | 24 |
| 9 | US20210264238A1 | Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views | 17 |
| 10 | US20220237898A1 | Machine learning system and method, integration server, information processing apparatus, program, and infere… | 15 |
Citation counts reflect influence within this searched corpus and skew toward older filings; they are not a measure of present-day importance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers mean for filing strategy
The dataset shows a field with high claim density in a few technology classes but no single assignee controlling the space, and momentum still building rather than settling.
No single filer dominates
The leading assignee holds 14 records and fifth place holds 7 — a gap, but not a moat. With the top 5 combining for only 22.6% of all 221 records and the top 10 for 33.0%, most of the field is held by entities with a handful of filings each, which means freedom-to-operate analysis has to look well beyond the named leaders.
Momentum is recent and real
Filings rose from 10 in 2021 to 30 in 2024, a +200% increase over three years, and 2025 posted the highest count in the dataset at 95 records. Because publication lags filing by about 18 months, the true 2025-26 volume is still being reported and will likely revise upward.
Claim density is lopsided
AI-model claims (G06N) and healthcare informatics (G16H) each touch a majority of records, while control-and-regulating claims (G05B) appear in only 3.6% of the 221 records. That gap is a proxy for where drafting effort has concentrated, not for where clinical need is greatest.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to medical ai & clinical analytics patent landscape, with the prior art for and against each one.
Who is filing, and where momentum is shifting
The ranked list covers 100 companies across the 221 records in scope. Most sit far below the leader, and year-over-year momentum is moving fast for a few of them.
A sharp recent acceleration
One university-affiliated filer moved to 11 records in the latest year, a +450% year-over-year jump, the fastest recent momentum in the ranked list. That kind of swing from a research-affiliated assignee is typical of a field still being explored rather than consolidated.
Early movers are slowing
Several assignees that filed steadily in prior years show sharp pullbacks in the latest year, including drops of -83% and -67% year over year. That pattern is consistent with publication lag rather than an actual retreat from the technology, since the most recent year is always undercounted.
Room below the leaders
With the top 10 assignees combining for only 33.0% of all 221 records, roughly two-thirds of the dataset sits with entities outside the visible ranking. Any competitive read of this space needs to look past the named leaders to the tail of single- and few-filing entrants.
| Assignee | Recent year | YoY |
|---|---|---|
| SR UNIVERSITY | 11 | +450% |
| VELLORE INSITUTE OF TECH | 2 | -83% |
| KONERU LAKSHMAIAH EDUCATION FOUNDATION | 1 | -67% |
| NEC Laboratories Europe GmbH | 0 | -100% |
| QURE AI TECH PTE LTD | 0 | — |
| TRAN BAO | 0 | — |
| Eko AI Pte Ltd | 0 | — |
| GE Precision Healthcare LLC | 0 | — |
Where to take this analysis
The figures above set the boundaries of the field; the next step is testing a specific claim or a specific competitor against them.
Check freedom-to-operate on a specific claim
Run a targeted search against the most-cited records and the representative filing before drafting claims in connectivity analysis, counterfactual explanation, or bedside inference.
Explore in Patsnap EurekaTrack momentum by assignee
Year-over-year swings as large as +450% and -83% show this field is still reordering; set alerts on the fastest-moving assignees rather than relying on the static ranking.
Explore in Patsnap EurekaMap the white space before filing
Thin classes like G05B and under-claimed branches such as federated training on patient records are where a first claim has more room to stand.
Explore in Patsnap EurekaCommon questions about this landscape
This dataset contains 221 published patent records filed between 2015 and 2026 that combine Medical AI claim language with clinical-analytics elements like training datasets, patient records or clinical decision logic. The count reflects a targeted search string rather than every AI-in-healthcare filing globally, so it should be read as a bounded sample of the field, not a total. Because publication lags filing by roughly 18 months, the most recent one to two years will likely be revised upward as more records surface.
The ranked list covers 100 companies, with the leading assignee holding 14 of the 221 records and the fifth-place assignee holding 7. No company controls a dominant share: the top 5 combined account for only 22.6% of all records and the top 10 for 33.0%. That means most of the filing activity sits with a long tail of universities, startups and individual inventors rather than a handful of large incumbents.
G06N (computing based on AI models) and G16H (healthcare informatics) are the two largest classes, covering 65.6% and 58.4% of the 221 records respectively. A61B (diagnosis and surgery), G06T (image data processing) and G06F/G06V follow as a secondary tier. Because a single record can carry several IPC classes, these percentages add up to more than 100% and describe overlapping claim coverage rather than a strict breakdown.
Yes, based on the years the dataset can treat as complete: filings grew from 10 in 2021 to 30 in 2024, a +200% increase over that three-year span, and 2025 recorded the highest raw count so far at 95 published records. The 2025 and 2026 figures are still incomplete due to normal publication lag, so they understate true filing activity for those years rather than signalling a slowdown.
Filing density is thin in a few identifiable branches relative to their clinical relevance, including closed-loop control of diagnostic AI systems (G05B overlaps with only 3.6% of records), federated model training directly on patient records, and real-time model inference on bedside or point-of-care devices. These are areas where claim space is comparatively open rather than crowded with prior art. A first-filer in one of these branches would face less direct claim overlap than in the densely claimed G06N and G16H classes.
A representative filing in this dataset, published as US20260188495A1 by University of Sharjah on 2026-07-02, claims an AI-based clinical decision support system that ingests brain scan data such as fMRI and EEG, analyses it using functional connectivity statistics with counterfactual explanations, and outputs a diagnosis plus attribution information identifying which connectivity features drove it. It illustrates how current claims combine multi-modal clinical input, model-based analysis and explainability into a single system rather than claiming any one element alone.
Research Medical AI & Clinical Analytics Patent Landscape in depth with Eureka
Go past this page: query the whole medical ai & clinical analytics patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.